Thailand expects to receive 61 million doses of AstraZeneca's (LON:AZN) COVID-19 vaccine this year and has plans to buy an additional 60 million doses in 2022, Reuters news agency reported on Monday.
Thailand's government spokesperson, Anucha Burapachaisri, stated that after a meeting between Thailand's Prime Minister, Prayuth Chan-ocha, and AstraZeneca CEO Pascal Soriot, the company said it would deliver 61 million COVID-19 vaccine doses to Thailand this year.
GSK secures EU approval for fully liquid Menveo vaccine
Scancell reports promising SCOPE trial data for SCIB1 in advanced melanoma
Transgene teams up with ProBioGen for individualised cancer vaccines
Bio-Works Technologies AB secures LOI for vaccine manufacturing product
LakeShore Biopharma's Phase III YSJA Rabies Vaccine clinical trial receives Chinese NMPA approval
Merck's CAPVAXIVE shows promising immune responses in adults at risk of pneumococcal disease
GSK PLC announces acceptance of NDA for gepotidacin by US FDA